Followers | 7 |
Posts | 604 |
Boards Moderated | 0 |
Alias Born | 03/08/2017 |
Thursday, August 17, 2017 9:30:17 PM
The completion of the Dakota Access pipeline has dramatically reduced shipping costs for companies operating in the Bakken shale, bringing overall costs in line with other U.S. shale producers, which should prove to be a "powerful advantage that we haven’t had for the past six or seven years,” Enerplus (NYSE:ERF) CEO CEO Ian Dundas tells Financial Post.
Before Dakota Access, ~25% of oil shipped out of North Dakota traveled by rail, but the figure is now 7%, and the increased availability of pipeline capacity has translated into much lower shipping costs for producers.
ERF was receiving a US$13/bbl discount for its oil in early 2014 vs. the WTI benchmark, mostly tied to higher shipping costs, but the total discount had shrunk to US$7 by last year and is expected to fall as low as US$3.50 in H2 2017, Dundas says.
“These are pretty dramatic moves when you talk about the lower margins that everyone is struggling with in a $50 oil world,” Dundas says.
Recent ERF News
- Eurofins Scientific SE: Purchases of Own Shares From the 29th of April 2024 to the 3rd of May 2024 • Business Wire • 05/06/2024 03:45:00 PM
- Eurofins Scientific SE: Purchases of Own Shares From the 25th to the 26th of April 2024 • Business Wire • 04/29/2024 03:45:00 PM
- Enerplus to Report First Quarter 2024 Results May 8 • PR Newswire (Canada) • 04/26/2024 10:00:00 AM
- Eurofins Achieves Organic Growth of 6.8% in Q1 2024, Ahead of Its Objectives • Business Wire • 04/24/2024 05:15:00 AM
- Chord Energy and Enerplus Announce Expiration of Hart-Scott-Rodino Act Waiting Period and Provide Transaction Update • PR Newswire (Canada) • 04/08/2024 10:00:00 AM
- Chord Energy and Enerplus Announce Expiration of Hart-Scott-Rodino Act Waiting Period and Provide Transaction Update • PR Newswire (US) • 04/08/2024 10:00:00 AM
- Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2024 • Business Wire • 04/05/2024 03:32:00 PM
- The Eurofins Network Expands Its Offering in Renal and Transplant Testing in the United States With the Acquisition of Ascend Clinical LLC • Business Wire • 04/03/2024 05:15:00 AM
- Eurofins: Purchases of Own Shares from the 18th to the 22th of March 2024 • Business Wire • 03/25/2024 04:45:00 PM
- Eurofins: Convening Notice of the Shareholders to the Annual Ordinary General Meeting and an Extraordinary General Meeting of the Company Valid as an Information Notice for the Bondholders • Business Wire • 03/25/2024 06:15:00 AM
- Eurofins: AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A UNE ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES • Business Wire • 03/25/2024 06:15:00 AM
- Eurofins: Purchases of Own Shares From the 11th to the 15th of March 2024 • Business Wire • 03/18/2024 04:45:00 PM
- Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 29 February 2024 • Business Wire • 03/12/2024 10:57:00 AM
- Eurofins: Purchases of Own Shares From the 5th to the 8th of March 2024 • Business Wire • 03/11/2024 04:45:00 PM
- Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets • Business Wire • 02/29/2024 06:00:00 PM
- Eurofins E&E and ETS-Lindgren Complete Half-Million-Dollar Expansion to Silicon Valley EMC Testing Facility • Business Wire • 02/29/2024 05:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/29/2024 02:16:41 PM
- Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE: A New AI-Driven Platform for Drug Discovery Trained Using Proprietary Datasets • Business Wire • 02/29/2024 06:15:00 AM
- Eurofins Delivers Strong Margin Improvement and Cash Generation in H2 2023 and Annual Results in Line With Its 2023 Objectives. Remains Confident to Achieve Its 2027 Objectives. • Business Wire • 02/27/2024 06:15:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/23/2024 10:26:58 PM
- Enerplus Announces an 8% Increase to its Quarterly Cash Dividend for March 2024 • PR Newswire (Canada) • 02/21/2024 10:45:00 PM
- Enerplus Announces Fourth Quarter and Full Year 2023 Financial and Operating Results • PR Newswire (Canada) • 02/21/2024 10:38:00 PM
- Enerplus Announces 2023 Year End Reserves Results • PR Newswire (Canada) • 02/21/2024 10:31:00 PM
- Eurofins MET Labs Recognized for Instrumental Support in Intuitive Machines’ IM-1 Lunar Mission • Business Wire • 02/20/2024 02:00:00 PM
- Eurofins: Purchases of Own Shares from the 12th to the 14th of February 2024 • Business Wire • 02/19/2024 04:45:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM